Skip to content

Study on the Classification and Efficacy of Meibomian Gland Dysfunction Based on Unsupervised Learning in Radiomics

Study on the Classification and Efficacy of Meibomian Gland Dysfunction Based on Unsupervised Learning in Radiomics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112870
Enrollment
Unknown
Registered
2025-11-20
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meibomian gland dysfunction

Interventions

Meibomian gland massage therapy group:None
OPT therapy group:None

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The subjects included in this study were patients who visited our hospital from January 2021 to December 2023 and were diagnosed with meibomian gland dysfunction (MGD). The diagnostic criteria are as follows: (1) Dry eye diagnosis is based on the 2020 Chinese Consensus on Dry Eye Experts: 1) Patients report at least one subjective symptom such as eye dryness, foreign body sensation, burning sensation, fatigue, discomfort, redness, or fluctuating vision; Chinese Dry Eye Questionnaire score >=7 or OSDI >=13; and the patient has FBUT =75 or OSDI >=13, and FBUT >5s but 5mm/5min but =5 points. (2) Diagnosis of meibomian gland dysfunction is based on the 2017 Chinese Expert Consensus on Diagnosis and Treatment of MGD: 1) Abnormal eyelid margin or meibomian gland orifices; 2) Abnormal meibum secretion; 3) Presence of ocular symptoms; 4) Meibomian gland loss; 5) Abnormal lipid layer thickness. The presence of any one of items 1) or 2), combined with ocular symptoms in item 3), allows for a diagnosis of symptomatic MGD.

Exclusion criteria

Exclusion criteria: 1. Patients with severe dry eye requiring surgical treatment; 2. Those who have undergone eyelid surgery within 6 months prior to screening; 3. Patients who have received permanent punctal plug treatment or temporary punctal plug treatment within 6 months prior to screening; 4. Surgery-induced dry eye; 5. Patients with glaucoma; 6. Active systemic or ocular infections; 7. Patients with recurrent viral keratitis; 8. Patients with concomitant ocular cicatricial pemphigoid, significant conjunctival scarring, ocular chemical burns, neurotrophic keratoconjunctivitis, or post-eyelid tumor excision.

Design outcomes

Primary

MeasureTime frame
Ocular Surface Disease Index Score;

Countries

China

Contacts

Public ContactLi Siyan

Eye Hospital, Wenzhou Medical University

syaine@126.com+86 18813185262

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026